This user currently has no profile.
A researcher into gene silencing as a technology for improving the lives of those suffering from incurable diseases. Benitec Biopharma is my primary investment in this technology as ddRNAi offers one-time treatments for a broad range of these diseases.
- Description: Retiree. Trading frequency: Monthly
- Interests: Tech stocks
Currently, you have no company profile. Click edit to add a company profile.
Currently, you have no blog details. Click edit to add blog details.
Currently, you have no book details. Click edit to add book details.
LATEST STOCKTALK more »
Latest Comments more »
- Tony, I think you are absol... on Cell Therapy Commercialization Not A Fit For Bi...
- I think that you are spot o... on TT-034 Clinical Trial Management
- Benitec has stated that it ... on Benitec's DdRNAi Targeting Fight Against HIV
- bioseeker, I get that you a... on TT-034 Safety Shown In First Patient Dosed
- And yet Alnylam has not com... on TT-034 Safety Shown In First Patient Dosed
Latest comments on Pannobhaso's Articles